CD38
CD38 is a multifunctional ectoenzyme that serves as the primary consumer of NAD+ in aging tissues. Its increased expression with age is a major driver of systemic NAD+ decline, making it a key target for interventions aimed at restoring metabolic and cellular energy.
Key Takeaways
- •CD38 is the "sink" that wastes your body’s NAD+ fuel as you age.
- •It is an ectoenzyme, meaning its active site faces the outside of the cell.
- •Increased CD38 expression is a primary driver of the NAD+ decline seen in biological aging.
- •Natural inhibitors like Apigenin (from parsley) can block CD38 to boost systemic NAD+ levels.
Basic Information
- Gene Symbol
- CD38
- Full Name
- CD38 Molecule
- Also Known As
- ADPRC 1T10
- Location
- 4p15.32
- Protein Type
- Ectoenzyme / Receptor
- Protein Family
- ADP-ribosyl cyclase family
Related Isoforms
Key SNPs
Marker associated with variations in CD38 expression and studied in the context of immune function and age-related metabolic traits.
Common marker used in GWAS panels to identify the CD38 locus and its association with diverse physiological and neurological outcomes.
Overview
CD38 (CD38 Molecule) is a versatile transmembrane protein that serves a dual role as both a cell surface marker and a powerful enzyme. It belongs to the ADP-ribosyl cyclase family and is responsible for the breakdown of NAD+ (Nicotinamide Adenine Dinucleotide) into cADP-ribose and nicotinamide. While CD38 has important functions in immune cell activation and calcium signaling, its primary significance in the context of longevity is its role as a "NAD+ consumer."
As we age, the expression of CD38 increases significantly across multiple tissues, particularly in the liver, fat, and immune system. This "up-regulation of the sink" causes a systemic drain on the body’s NAD+ stores, starving longevity-promoting enzymes like sirtuins and PARPs of their essential fuel. Consequently, CD38 has emerged as a central target for "anti-aging" research, with scientists looking for ways to selectively quiet this enzyme to restore youthful energy and repair capacity.
Conceptual Model
A simplified mental model for the pathway:
CD38 decides how much of your NAD+ "bank account" is wasted vs. used for repair.
Core Health Impacts
- • NAD+ Homeostasis: The primary genetic determinant of systemic NAD+ degradation in aging
- • Calcium Signaling: Produces cADPR and NAADP, essential messengers for intracellular calcium release
- • Immune Activation: Acts as a signaling hub for T-cell and B-cell migration and adhesion
- • Metabolic Pace: Directly influences mitochondrial function by controlling the availability of the NAD+ cofactor
- • Social Behavior: Involved in the regulation of oxytocin release, impacting social and emotional traits
Protein Domains
Ecto-enzymatic Domain
The large extracellular portion of the protein containing the catalytic site for NAD+ hydrolysis.
Transmembrane Helix
A single segment that anchors the protein in the membrane, usually with the catalytic side facing out.
Internalization Motif
Specific sequences that allow the protein to flip its orientation or move into the cell during signaling.
Upstream Regulators
Inflammaging (Cytokines) Activator
Pro-inflammatory signals like TNF-α and IL-6 potently upregulate CD38 expression with age.
SASP Factors Activator
Chemicals secreted by senescent cells directly trigger the increase of CD38 in surrounding tissues.
Estrogen Modulator
Reported to influence CD38 levels in reproductive and metabolic tissues.
Nutritional Excess Activator
High-fat and high-sugar diets can enhance the inflammatory environment that drives CD38 induction.
Downstream Targets
NAD+ (Substrate) Inhibits
The primary target of destruction; CD38 cleaves NAD+ into nicotinamide and ADP-ribose.
cADP-ribose Activates
A product of CD38 that acts as a potent second messenger for calcium signaling.
Sirtuins (SIRT1/3/6) Inhibits
Indirectly inhibited by CD38 through the depletion of their essential NAD+ fuel.
Mitochondrial Function Inhibits
Systemic energy production falls as CD38-mediated NAD+ loss impairs mitochondrial enzymes.
DNA Repair (PARPs) Inhibits
Genomic maintenance is compromised when CD38 "steals" the NAD+ needed for repair.
Role in Aging
CD38 is perhaps the most significant "drain" on human longevity. Its activity creates a systemic "fuel crisis" that prevents the body from running its own repair and maintenance programs, making it a primary driver of the functional decline seen in aging.
The NAD+ Sink
The age-related surge in CD38 is the leading cause of the 50% drop in systemic NAD+ levels seen by age 50.
Inflammaging Switch
CD38 is the molecular bridge between chronic inflammation and metabolic failure in the elderly.
Mitochondrial Decay
Loss of NAD+ due to high CD38 activity prevents the healthy recycling of mitochondria (mitophagy).
Vascular Stiffening
High CD38 levels in blood vessels impair nitric oxide production, contributing to age-related hypertension.
Immunosenescence
Excessive CD38 signaling can lead to T-cell exhaustion and a reduced ability to fight new infections.
Cognitive Decline
Declining brain NAD+ levels, driven by CD38, contribute to the synaptic failure and energy crisis of dementia.
Disorders & Diseases
Metabolic Syndrome
CD38 over-activity in fat tissue is a major driver of insulin resistance and chronic low-grade inflammation.
Chronic Lymphocytic Leukemia
High CD38 expression on leukemic cells is a marker of aggressive disease and poor clinical prognosis.
Alzheimer’s Disease
Increased CD38 in the brain is linked to neuroinflammation and the failure of amyloid clearance pathways.
Type 2 Diabetes
Failure of insulin secretion can be exacerbated by CD38-mediated depletion of NAD+ in pancreatic beta-cells.
Obesity-Related Inflammation
Fat tissue expansion triggers a massive up-regulation of CD38, creating a systemic inflammatory state.
The Aging Trap
CD38 creates a vicious cycle of aging. Inflammation increases CD38, which lowers NAD+, which then prevents the cell from repairing the damage that causes inflammation. Breaking this loop is the "holy grail" of systemic rejuvenation.
Interventions
Supplements
A natural flavonoid found in parsley and celery that is a potent inhibitor of the CD38 enzyme.
Reported to have CD38-inhibitory activity, contributing to its systemic anti-inflammatory effects.
Another natural flavonoid studied for its ability to block the "NAD+ sink" and support metabolic health.
NAD+ precursors that work by filling the "tank" while CD38 continues to drain it; most effective when paired with inhibitors.
Lifestyle
Reducing systemic inflammation lowers the primary stimulus (cytokines) that turns on the CD38 gene.
Supports the NAMPT recycling pathway, which helps counter-balance the NAD+ loss driven by CD38.
Can modulate the immune-metabolic environment to favor lower CD38 expression and higher sirtuin activity.
May support the proteostatic mechanisms that manage the high-turnover protein environment of aging.
Medicines
A monoclonal antibody that targets CD38 to kill myeloma cells; used primarily in oncology but highly relevant to the pathway.
A potent, selective research inhibitor of CD38 that has been shown to reverse metabolic aging in animal models.
Next-generation "degraders" designed to selectively remove the CD38 protein from aging tissues.
Drugs that clear the senescent cells that produce the SASP signals that upregulate CD38.
Lab Tests & Biomarkers
Metabolic Profiling
The definitive measure of the "net balance" between NAD+ production (NAMPT) and destruction (CD38).
Reflects the recycling capacity that must compete with the CD38-mediated drain.
Immune Markers
Measures the density of the protein on individual immune cells; used in both aging and oncology diagnostics.
High levels suggest an environment that is currently upregulating the CD38 "sink."
Genetic Screening
Assesses the baseline genetic predisposition toward variations in CD38 density and NAD+ turnover.
Combines CD38 status with SIRT1 and FOXO3 to profile systemic aging resilience.
Hormonal Interactions
Cortisol Modulator
Chronic high stress and cortisol can promote the inflammatory state that induces CD38 expression.
Insulin Activator
High levels in metabolic syndrome are associated with the up-regulation of CD38 in adipose tissue.
Growth Hormone Regulator
Supports the systemic environment required for metabolic precision and cofactor maintenance.
Thyroid Hormone Modulator
Sets the metabolic pace of the liver and brain, impacting the total turnover of the NAD+ pool.
Deep Dive
Network Diagrams
CD38: The NAD+ Sink
The Molecular Sink: CD38 and NAD+ Waste
To understand CD38, one must view the cell as a high-performance machine powered by a specific fuel: NAD+. For the machine to stay young and repair itself, it needs a full tank of fuel. CD38 is the biological leak in that tank.
The Ectoenzyme: CD38 is an enzyme that lives on the outside of our cells. Its primary job is to find NAD+ and destroy it, breaking it down into smaller, useless pieces. While CD38 has some important roles in calcium signaling, its most significant impact on human health is its role as a “waster” of cellular energy.
The Sink of Aging: CD38 is one of the only enzymes in the body that increases as we age. In a young person, the “leak” is very small. But by middle age, the CD38 leak has become a wide-open drain. This age-related surge in CD38 is the primary reason why our NAD+ levels plummet as we get older, effectively starving our longevity enzymes (sirtuins) of the fuel they need to keep us healthy.
The Inflammaging Loop: Why the Sink Opens
The most important discovery in CD38 research is what causes the gene to turn on.
The SASP signal: As we age, our bodies accumulate senescent cells (damaged “zombie” cells). These cells are not silent; they secrete a “toxic soup” of inflammatory chemicals called the SASP.
- The Chain Reaction: These SASP chemicals travel to neighboring healthy cells and tell them to produce more CD38.
- The Result: This creates a vicious cycle known as inflammaging. Chronic low-grade inflammation drives up CD38, which destroys NAD+, which then makes the cells too weak to repair the damage that caused the inflammation in the first place.
Apigenin: Plugging the Leak
The discovery that CD38 is the primary “sink” for NAD+ has led to a major breakthrough in longevity nutrition: Apigenin.
The Molecular Plug: Apigenin is a natural flavonoid found in plants like parsley, celery, and chamomile. Scientists have discovered that Apigenin is a potent inhibitor of the CD38 enzyme.
- The Restoration: By taking Apigenin, you are essentially putting a plug in the CD38 drain.
- Restoring Youth: In animal studies, blocking CD38 with Apigenin or other drugs instantly restores youthful NAD+ levels. It improves heart function, sharpens the mind, and restores metabolic flexibility.
This proves that maintaining NAD+ is a two-part game: you must produce it (via genes like NAMPT), but you must also stop wasting it (via CD38). For anyone interested in biological aging, CD38 is the definitive “bottleneck” that must be managed to maintain a high-performance cellular engine for life.
Practical Note: Plugging the Leak
बैंक Account vs. Spending. Taking NAD+ precursors (like NMN) is like putting money into your bank account. CD38 activity is like an automatic monthly bill that gets larger as you age. If your "bills" (CD38) are too high, your bank account will always be empty no matter how much you "earn" (supplement). Plugging the CD38 leak with inhibitors like Apigenin is the essential second half of an NAD+ strategy.
Parsley and Celery. These common foods are the richest natural sources of Apigenin. Including them daily in your diet provides a constant, low-level inhibition of the CD38 "sink," supporting your body's natural energy and repair capacity as you age.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
The landmark study that proved CD38 is the primary enzyme responsible for the decline of NAD+ during biological aging.
Comprehensive review characterizing the structural biology, signaling, and clinical significance of the CD38 receptor.
Demonstrated that pharmacological blockade of CD38 can restore youthful NAD+ levels and cardiac function in aged mammals.
First major study to establish CD38 as a primary prognostic marker for the clinical course of B-cell cancers.
Provided the high-resolution crystal structure of the CD38 active site, revealing its unique catalytic pocket for NAD+ capture.